Fibrinogen, with or without its conversion to fibrin, in the extravascular spaces of injured and inflamed lung tissues is thought to promote inflammatory responses that can eventually lead to pulmonary fibrosis. One of these responses likely involves the elaboration of the proinflammatory cytokine interleukin (IL)-1 ␤ . We reported that both fibrinogen and fibrin stimulated production of IL-1 ␤ message and protein by binding to CD18 integrin receptors on normal human monocytes ( J. Immunol., 1995;154:1879-1887. The purpose of the current work was to extend our previous observations by characterizing the transcriptional regulation of fibrinogen-induced IL-1 ␤ expression. Our model was the human monocytic cell line U937 transfected with the human IL-1 ␤ promoter connected to reporter genes. We found that fibrinogen induced the IL-1 ␤ promoter and that induction could be blocked by anti-CD18 antibody. Transfection with deletion constructs of the promoter and DNA electrophoresis mobility gel shift assays suggested that sequences containing activator protein (AP)-1, cyclic adenosine monophosphate response element (CRE), and nuclear factor (NF)-B cis -acting motifs regulate IL-1 ␤ gene expression by fibrinogen. In combination with competitive cotransfection studies using consensus oligonucleotides mimicking these motifs, we conclude that transactivation of an NF-B-like sequence is necessary for induction of the IL-1 ␤ gene, that activation of CRE may repress induction of the gene, and that AP-1 potentially modulates induction and repression of the gene induced by fibrinogen. This study begins to define the molecular mechanisms by which fibrin(ogen) promotes and regulates expression of the IL-1 ␤ gene and further substantiates a role for fibrin ( Leakage of fibrinogen and fibrin formation is seen in lungs of patients with acute and chronic forms of lung injury (1-4). Studies investigating the role of this molecule in lung injury have focused on the mechanisms of fibrin formation and clearance in the lung that favor fibrin deposition (4-6), but little is known about the effects of fibrin(ogen) on the inflammatory response. There is evidence suggesting that fibrin, as a major component of a "provisional matrix" for the adhesion and migration of macrophages, fibroblasts, and epithelial cells (7, 8) , also activates inflammatory cells to produce mediators that may ultimately lead to fibrosis (9-12). Fibrosis can be especially catastrophic in the lung, where the integrity of gas exchange tissues is paramount. In a previous study, we observed that fibrin(ogen) was codistributed with the proinflammatory cytokine interleukin (IL)-1 ␤ in the lung granulomas of patients with pulmonary sarcoidosis, and hypothesized that fibrin could stimulate cells to express this granulomagenic cytokine (13). This hypothesis was supported by experiments showing that fibrin and its precursor fibrinogen stimulated expression of both IL-1 ␤ messenger RNA (mRNA) and protein in normal human monocytes in vitro , and that induction occurred, in part, via binding to the CD11b/CD18 integrin receptor. Studies to date, then, suggest that the injured lung allows fibrinogen leakage into lung interstitium and alveoli with formation of fibrin. Fibrin(ogen), in turn, may play a multifunctional role in inflammation by providing an extracellular matrix support 
Leakage of fibrinogen and fibrin formation is seen in lungs of patients with acute and chronic forms of lung injury (1) (2) (3) (4) . Studies investigating the role of this molecule in lung injury have focused on the mechanisms of fibrin formation and clearance in the lung that favor fibrin deposition (4-6), but little is known about the effects of fibrin(ogen) on the inflammatory response. There is evidence suggesting that fibrin, as a major component of a "provisional matrix" for the adhesion and migration of macrophages, fibroblasts, and epithelial cells (7, 8) , also activates inflammatory cells to produce mediators that may ultimately lead to fibrosis (9) (10) (11) (12) . Fibrosis can be especially catastrophic in the lung, where the integrity of gas exchange tissues is paramount. In a previous study, we observed that fibrin(ogen) was codistributed with the proinflammatory cytokine interleukin (IL)-1 ␤ in the lung granulomas of patients with pulmonary sarcoidosis, and hypothesized that fibrin could stimulate cells to express this granulomagenic cytokine (13) . This hypothesis was supported by experiments showing that fibrin and its precursor fibrinogen stimulated expression of both IL-1 ␤ messenger RNA (mRNA) and protein in normal human monocytes in vitro , and that induction occurred, in part, via binding to the CD11b/CD18 integrin receptor. Studies to date, then, suggest that the injured lung allows fibrinogen leakage into lung interstitium and alveoli with formation of fibrin. Fibrin(ogen), in turn, may play a multifunctional role in inflammation by providing an extracellular matrix support for the accumulation of inflammatory cells and by modifying cellular responses such as cytokine expression.
The purpose of this work was to characterize the transcriptional regulation of fibrinogen-induced IL-1 ␤ expression using the human monocytic cell line U937 transfected with constructs of the IL-1 ␤ promoter. The results indicate that fibrinogen, by binding the CD18 ( ␤ 2 ) integrin receptor, regulates IL-1 ␤ gene expression via promoter regions containing specific response elements known to regulate IL-1 ␤ gene expression. This work begins to delineate the intracellular mechanisms responsible for modulation of cytokine expression by fibrinogen and fibrin matrices.
Materials and Methods

Cell Culture and Treatment
Human histiocytic lymphoma U937 cells (American Type Culture Collection CRL no. 1593.2, Rockville, MD), were maintained in RPMI-1640 supplemented with 10% heatinactivated fetal bovine serum (FBS; Atlanta Biologicals, Norcross, GA), 1% antibiotic-antimycotic (100 U/ml penicillin G sodium, 100 U/ml streptomycin sulfate, and 0.25 g/ml amphotericin B), and incubated at 37 Њ C in a humidified 5% CO 2 incubator.
Fibrinogen (American Diagnostica, Greenwich, CT) was used at a concentration of 500 g/ml to stimulate induction of the IL-1 ␤ promoter. The dose of fibrinogen chosen for this work was determined on the basis of preliminary dose-response studies showing that 500 g/ml of fibrinogen was the maximal stimulatory concentration. The dose-response studies were performed without costimulants, such as adenosine diphosphate (ADP) or ionomycin, which have been shown to increase the ligand-binding affinity of CD11b/CD18 receptors (14) . Experimental manipulations included anti-CD18 monoclonal antibody (mAb) (MAB1962; Chemicon, Temecula, CA), nonimmune murine immunoglobulin (Ig)G (Ab5, 12.5 g/ml; Sigma, St. Louis, MO), consensus double-stranded activator protein (AP)-1 oligonucleotide (20 g/ml), consensus doublestranded nuclear factor (NF)-B oligonucleotide, and consensus double-stranded cyclic adenosine monophosphate (cAMP) response element (CRE) oligonucleotide (20 g/ ml). Oligonucleotides were synthesized by Oligos Etc. (Guilford, CT).
Screening for Lipopolysaccharide Contamination
Strict measures were taken to avoid lipopolysaccharide (LPS) contamination of the culture system. Lyophilized fibrinogen from the manufacturer was reconstituted in endotoxin-free water (Sigma) and rotated at 4 Њ C in B-52 END-X endotoxin removal devices (Associates of Cape Cod, Inc., Woods Hole, MA) for 4 h. The anti-CD18 antibody and nonimmune IgG were treated similarly using the smaller B-15 endotoxin removal devices from the same manufacturer. The reagents were tested for endotoxin using a timed gel Limulus amebocyte lysate (LAL) assay (Sigma) that has a lower limit of detection of 3.9 pg endotoxin/ml. The treated fibrinogen and antibodies did not clot the LAL protein, even below the lower detection limit, and were deemed to be endotoxin-free. The fibrinogen was lyophilized and stored under sterile conditions at Ϫ 70 Њ C until used. Fibrinogen was reconstituted in endotoxin-free RPMI 1640 at 2 mg/ml immediately before use. The antibodies were aliquoted in sterile cryotubes and stored at Ϫ 70 Њ C until used.
Transient Transfections and Chloramphenicol Acetyl Transferase Assay
Lipofectin reagent (Life Technologies, Gaithersburg, MD) was used for transfection of U937 cells with all IL-1 ␤ chloramphenicol acetyl transferase (CAT) promoter deletion constructs. Briefly, U937 cells were plated at 2 ϫ 10 6 cells/ml in 100-mm tissue culture dishes 24 h before transfection. Immediately before transfection, cells were washed with 14 ml of Cellgro complete serum-free medium, followed by the addition of 10 g of IL-1 ␤ CAT promoter construct, or 10 g of cytomegalovirus-CAT construct (pJM750-CAT; Merck, Sharp & Dohme, West Point, PA), 5 g of ␤ -galactosidase ( ␤ gal) plasmid DNA (Promega, Madison, WI), and 50 g of lipofectin, and incubated for 16 h at 37 Њ C and 5% CO 2 . IL-1 ␤ CAT promoter deletion constructs were previously described by Gray and colleagues (15) . Constructs included the fulllength 4.0-kb IL-1 ␤ promoter-CAT construct, pIL1 (4.0-kb) CAT, pIL1 (2.98-kb) CAT, and pIL1 (2.8-kb) CAT. Transfectants were stimulated with 500 g/ml fibrinogen for 16 h; the incubation period was determined by timecourse experiments showing maximal expression at 16 h. The stimulated cells were washed twice with 15 ml of calcium-and magnesium-free phosphate-buffered saline (PBS), resuspended in 300 l of reporter lysis buffer (Promega), and incubated at room temperature for 15 min. The cell extracts were then tested for CAT and ␤ gal activity.
CAT activity was measured according to Gorman and associates (16) . First, the samples were normalized to total protein measured by the Bradford method using Coomassie blue G-250 (Bio-Rad, Hercules, CA) (17) . Radiolabeled chloramphenicol (0.25 mCi of D -threo-[dichloroacetyl-1-14 C] chloramphenicol) and acetyl coenzyme A (4 mM) were added to samples containing 100 g total protein or standard CAT enzyme in 150 l of 0.25 M TrisHCl, pH 7.8. Samples were incubated at 37 Њ C for 4 h, ethyl acetate was extracted, and samples were separated by thin layer chromatography for 1.5 h in a 95:5 ratio of chloroform to methanol. Radioactive acetylated and nonacetylated products were quantified by PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Transfection efficiency was determined by cotransfection with ␤ gal plasmid DNA. Cell extract (150 l) or diluted ␤ gal enzyme was added to an equal volume of 2 ϫ assay buffer (120 mM Na 2 HPO 4 , 80 mM NaH 2 PO 4 , 2 mM MgCl 2 , 100 mM ␤ -mercaptoethanol, and 1.33 mg/ml O -nitrophenyl-␤ -D -galactopyranoside), mixed, and incubated at 37 Њ C for 3 h. The reaction was terminated with 500 l 1 M NaCO 3 , and the optical density was analyzed by spectrophotometry at a wavelength of 420 nm.
Transient Transfections and Luciferase Assay
Studies of the neutralizing effects of the anti-CD18 antibody and cotransfection experiments with consensus oligonucleotides were performed with IL-1 ␤ promoter con-structs attached to the luciferase (LUC) gene. Compared with the CAT gene constructs, the LUC gene constructs were more rapidly and reproducibly inducible and did not involve the use of radioactivity. Thus, the bulk of the experiments reported were performed using the LUC constructs.
Transfection of U937 cells with IL-1 ␤ LUC promoter deletion constructs was performed by electroporation. LUC constructs, pIL1 (4.0-kb) LUC and pIL1 (3.1-kb) LUC, were made by restriction digest of the full-length IL-1 ␤ promoter with either Xba I or Pvu II, respectively, and ligated into the LUC reporter vector pGL3 (Promega). Briefly, cells were washed twice with 30 ml PBS and added to Cellgro complete serum-free medium (MediaTech, Herndon, VA) supplemented with 10 mM dextrose and 0.1 mM dithiothreitol (DTT) to a final concentration of 6 ϫ 10 7 cells/ml. U937 cells (4.8 ϫ 10 7 ) were added to electroporation cuvettes (0.4-cm electrode gap) along with 40 g pIL1 (4.0-kb) LUC or pIL1 (3.1-kb) LUC plasmid DNA, 20 g ␤ gal plasmid DNA, and, in cotransfection studies, 20 g of consensus double-stranded phosphorothioate oligonucleotides, and subjected to 400 V and 1075 F (Gene Pulser II electroporation system; Bio-Rad). Electroporated cells were pooled, aliquoted into 24-well plates, and incubated with or without fibrinogen (500 g/ ml) for 6 h at 37 Њ C and 5% CO 2 . The incubation period was determined by time-course experiments showing maximal expression at 6 h for the promoter-LUC constructs.
For the antibody neutralization studies, cells were preincubated for 1 h at 37 Њ C and 5% CO 2 with the anti-CD18 murine mAb MAB1962 or the nonimmune control murine IgG Ab5. MAB1962, provided as lyophilized ascites, was reconstituted per the manufacturer's instructions (100 l PBS) and used at a final dilution of 1:200 in culture. The control IgG Ab5 was used at a final concentration of 12.5 g/ml.
After incubation with the various treatments, cells were harvested, washed with PBS, and resuspended in 100 l cell lysis buffer (25 mM Tris-phosphate, pH 7.8; 2 mM DTT; 2 mM 1,2-diaminocyclohexane-N , N , N Ј , N Ј -tetraacetic acid; 10% glycerol; and 1% Triton X-100), and a 20-l aliquot was tested for LUC activity by adding 50 l Luciferase Assay Reagent (20 mM ). Light intensity was measured using a Dynatech ML 3000 microtiter plate luminometer (Chantilly, VA). Results were recorded as relative LUC units and standardized for transfection efficiency using ␤gal activity.
Cotransfection studies using complementary consensus oligonucleotides for AP-1, CRE, or NF-B with pIL1 (4.0-kb) LUC or pIL1 (3.1-kb) LUC plasmid DNA were performed. The phosphorothioate-protected oligonucleotides for AP-1 (CGCTTGATGACTCAGCCGGAA), CRE (AGAGATTGCCTGACGTCAGAGAGCTAG), and NF-B (ATGTGAGGGGACTTTCCCAGGC) were annealed in 200 mM NaCl by heating to 94ЊC for 7 min and cooling slowly to 4ЊC.
DNA Electrophoresis Mobility Gel Shift Assay
U937 cells (1 ϫ 10 8 ) were grown in suspension in RPMI-1640 supplemented with 10% heat-inactivated FBS, 1% antibiotic/antimycotic, in 75-mm tissue culture flasks with or without 500 g/ml LPS-free fibrinogen at 37ЊC in a 5% CO 2 incubator. Some experiments included cells treated with LPS at 10 g/ml. Cells were treated for 16 h and washed with ice-cold PBS, and nuclear binding proteins were extracted. Proteins were extracted in buffer containing 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 25% glycerol, 0.5 mM phenylmethylsulfonyl fluoride, 5 g/ml leupeptin, 1% aprotinin, 5 g/ml pepstatin A, and 20 mM N-2-hydroxyethylpiperazine-NЈ-2-ethane sulfonic acid (Hepes), pH 7.9. Protein concentrations were determined by the Bradford method using the Bio-Rad protein assay reagent as described previously.
Double-stranded AP-1, CRE, or NF-B consensus oligonucleotides were radiolabeled with 33 P-␥ ATP using T4 polynucleotide kinase enzyme. A total of 5 g of nuclear protein was incubated with radiolabeled AP-1, CRE, or NF-B (1 to 200,000 counts per min/ng) for 30 min at room temperature in a reaction mixture containing 15 mM Hepes, 90 mM KCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, and 0.1 g/reaction poly(deoxyinosine/deoxycytidine). The DNA-protein complexes were separated on 6% native polyacrylamide gels (20:1 acrylamide/bis ratio) in low ionic-strength buffer (22.25 mM Tris borate, 22.25 mM boric acid, 500 mM EDTA) for 2 to 3 h at 4ЊC at 10 V/ cm 2 . Gels were fixed in a 10% acid/10% methanol solution for 10 min, dried under vacuum, and exposed to X-ray film. For the competition studies, 50-fold molar excess of nonradiolabeled double-stranded oligonucleotides was added to the reaction mix.
Statistical Analysis
Mean values are presented Ϯ 1 SEM in all figures. Because more than two treatments with a single independent categorical value were compared, one-way analysis of variance (ANOVA) was used. The Student-Newman-Keuls (SNK) test for multiple comparisons was then used to test for differences between pairs of means (18) .
Results
The IL-1␤ Promoter Is Induced by Engagement of the CD18 (␤ 2 ) Integrin Receptor by Fibrinogen
To determine whether the effects of fibrinogen on IL-1␤ gene transcription in the U937 cell line were mediated through CD18 receptors, neutralization experiments were performed using the anti-CD18 antibody MAB1962. U937 cells transfected with the full-length 4.0-kb IL-1␤ promoter-LUC construct were exposed to fibrinogen with or without pretreatment with MAB1962 at a final dilution of 1:200 from the manufacturer's preparation. Figure 1 shows that fibrinogen averaged almost three times greater stimulation of the construct than did unstimulated control cells (seven experiments, range 1.8 to 4.4 times the control value of 1). Control murine IgG did not affect constitutive or fibrinogen-induced levels of IL-1␤. The anti-CD18 antibody MAB1962 alone did not induce the IL-1␤ promoter. The ANOVA for the effects of the antibodies on fibrinogen-treated cells gave a level of P ϭ 0.019. Both fibrinogen and fibrinogen ϩ IgG stimulated the IL-1␤ promoter, and there were no significant differences between them. Both fibrinogen and fibrinogen ϩ IgG each produced greater stimulation of the promoter than did fibrinogen ϩ MAB-1962, P Ͻ 0.05. Serial dilutions of MAB1962 produced correspondingly less inhibition of fibrinogen-induced IL-1␤ promoter expression (Figure 2) . These experiments indicate that expression of the IL-1␤ promoter by fibrinogentreated U937 cells, like normal leukocytes, is mediated via CD18 receptors.
LPS Does Not Induce the IL-1␤ Promoter
Transfected in U937 Cells LPS, a potent inducer of IL-1␤ in normal monocytes (19, 20) , was carefully monitored to assure that induction produced by fibrinogen was not due to contaminating LPS. Additionally, five experiments using U937 cells transfected with the inducible 4.0-kb promoter exposed to 10 g/ml LPS (Sigma) yielded a relative stimulation of only 1.15 Ϯ 0.08 SEM. This level of stimulation was significantly less than stimulation with fibrinogen alone (P ϭ 0.003). Undifferentiated U937 cells, in fact, do not express IL-1␤ in the presence of LPS (15, 21) . Because of the care taken to eliminate LPS from our system, we are confident that LPS did not account for any of our results.
Fibrinogen-Response Elements in IL-1␤ Promoter Regions
Are Located Near, or Include, AP-1, CRE, and NF-B To explore which regions in the IL-1 ␤ promoter are important for fibrinogen-induced IL-1␤ expression, 5Ј-deletion constructs of the promoter linked to the CAT reporter gene were transfected into U937 cells and stimulated with fibrinogen. This was done by making discrete deletions of the fibrinogen-inducible 4.0-kb IL-1␤ promoter sequence, producing a 2.98-kb construct and a 2.8-kb construct lacking a CRE-like motif found in the most upstream 180 base pairs (bp) of the construct ( Figure 3A ).
As seen with the 4.0-kb LUC construct in Figure 1 , the 4.0-kb CAT construct was also stimulated by fibrinogen ( Figure 3B ). The 2.98-kb CAT construct, missing two upstream AP-1 response elements (positions Ϫ3491 and Ϫ3116) and two AP-1-like regions (positions Ϫ3194 and Ϫ3103), was not induced by fibrinogen. However, further deletion, including removal of the CRE-like site (position Ϫ2865, six of eight consensus nucleotides), produced the 2.8-kb IL-1␤ promoter construct that was fully inducible by fibrinogen. The 2.8-kb construct contains an NF-B-like element at position Ϫ2756 flanked immediately upstream by a CRE/AP-1 motif at position Ϫ2764. The alternate induction, suppression, and reinduction of the sequential deletion constructs by fibrinogen suggested an interdependent association between promoter regions containing AP-1, CRE, and NF-B response elements in the regulation of IL-1␤.
Statistical analysis using ANOVA of the IL-1␤ promoter deletion construct expression by fibrinogen-stimulated cells gave a level of P ϭ 0.083, too large to perform multiple comparisons by the SNK test. Given this level of significance, we estimate a 10% chance that the observed differences between the inducible 4.0-and 2.8-kb constructs and the noninducible 2.98-kb construct could have occurred by chance alone. However, the corroborative competitive cotransfection studies described below showed highly significant differences and thus increase the likelihood that our findings with the deletion constructs are real.
Fibrinogen Induces DNA-Binding Activity of AP-1, CRE Binding Protein, and NF-B Nuclear Binding Proteins
The deletion studies implied that AP-1, CRE, and NF-B response elements could be important in fibrinogeninduced IL-1␤ expression. DNA electrophoresis mobility gel shift assays were performed to determine whether nuclear binding proteins corresponding to these response elements were activated upon fibrinogen stimulation. Figure  4 shows a representative gel of five separate experiments, with competition oligonucleotides in two of the experiments showing that fibrinogen induced greater DNAbinding activity of the nuclear binding proteins AP-1, CRE binding protein (CREB), and NF-B compared with no fibrinogen treatment in U937 cells. Incubation with excess unlabeled AP-1, CRE, and NF-B consensus oligonucleotides competed out their respective nuclear binding proteins from fibrinogen-treated cells to labeled probe. LPS-stimulated cells did not significantly increase activation of any of these binding factors (not shown).
We should point out that nuclear binding proteins were extracted after 16 h of incubation with fibrinogen, on the basis of our experience with the IL-1␤ promoter-CAT transfections. Translocation/activation of the nuclear binding proteins upon stimulation with fibrinogen probably occurs much sooner and possibly with greater binding than later. Nevertheless, the shifts in oligonucleotide-bound proteins were clear.
Transactivation of NF-B Is Required for the Induction of the IL-1␤ Promoter by Fibrinogen
Competitive cotransfection studies using consensus oligonucleotides mimicking AP-1, CRE, and NF-B cis-acting regions were performed to determine which sites on the IL-1␤ promoter repressed or enhanced transcription. Neither AP-1 nor CRE consensus oligonucleotides prevented induction of the full-length 4.0-kb LUC IL-1␤ promoter by fibrinogen ( Figure 5 ). In contrast, NF-B consensus oligonucleotides prevented fibrinogen induction of IL-1␤. ANOVA comparing fibrinogen treatment alone with fibrinogen ϩ competitive oligonucleotides gave a value of P ϭ 0.02. Multiple-comparison testing showed that only competition with NF-B oligonucleotide was significantly different from fibrinogen treatment alone (P Ͻ 0.05). Thus, transactivation of NF-B or NF-B-like sequences appears to be required for induction of the IL-1␤ gene.
Transactivation of CRE Represses Induction of the IL-1␤ Promoter by Fibrinogen
Experiments using the 5Ј-deletion constructs and DNA mobility gel shift assays indicated that transactivation of CRE by CREB can suppress IL-1␤ expression under certain conditions. To determine whether occupancy of CRE by its nuclear binding protein CREB could repress induction of the IL-1␤ promoter, studies were performed 6, and 10) . A 50-fold molar excess unlabeled competitor successfully competed out all three nuclear binding proteins (lanes 4,  8, and 12) . Bound probe is indicated by the letter B. The first lane in each set shows migration of the unbound or free (F) probe (the CRE extracts in the gel shown had high levels of protein, so free probe was retained at the origin). The shift pattern of this gel is representative of five separate experiments, with competition oligonucleotides in two of the experiments. using the 3.1-kb LUC 5Ј-deletion construct cotransfected with the CRE consensus oligonucleotide. Like the 2.98-kb CAT construct, the 3.1-kb LUC construct was not induced by fibrinogen (Figure 6 ). Cotransfection with competitive CRE oligonucleotides allowed recovery of promoter induction by fibrinogen. Recovery of promoter induction was significant, as determined by ANOVA comparing the effect of CRE cotransfection on fibrinogen stimulation with fibrinogen or CRE treatment alone (P Ͻ 0.0001). Multiple-comparison testing showed that cotransfection with CRE oligonucleotide followed by fibrinogen treatment produced greater stimulation than fibrinogen treatment alone (P Ͻ 0.05). These findings support a role for CRE as a repressor element.
Discussion
This study extends our observations that fibrinogen induces expression of IL-1␤ in a specific receptor-mediated way. We show that fibrinogen affects expression through regions in the IL-1␤ gene promoter that contain motifs important in the regulation of the IL-1␤ gene (15, 22) . The results implicate regions containing AP-1, CRE, and NF-B-like response elements in the control of IL-1␤ expression induced by fibrinogen.
The IL-1␤ Promoter Is Induced by Fibrinogen Engagement of the CD18 (␤ 2 ) Integrin Receptor
Fibrinogen binding to leukocytes has been well established (23), but only recently have the specific receptors and binding dynamics been described (24, 25) . Like other extracellular matrix proteins, such as fibronectin and collagen, fibrin binds to cells via heterodimeric integrin receptors. The family of ␤ 2 integrins, designated CD18, are the primary receptors for fibrinogen on leukocytes (reviewed in Ref. 26) . Fibrin(ogen) binding to leukocytes is mediated mainly via the integrin receptor designated CD11b/CD18 (also termed Mac-1 or CR3) (27, 28) , but binding to CD11c/CD18 has also been shown (29) . In this report, we demonstrate with antibody-blocking studies that a CD18 receptor in U937 cells is responsible for the IL-1␤ promoter-inducing effects of fibrinogen. This finding was expected on the basis of the studies cited above and our own study using normal monocytes (13) . The results reported here confirm that fibrinogen interacts with U937 cells via the same family of CD18 receptors found on normal leukocytes. In addition, neutralization studies in progress show that the anti-CD11b mAbs 2LPM19c (DAKO, Carpinteria, CA), and D12 (Becton Dickinson, Bedford, MA) also inhibit induction of the IL-1␤ promoter by fibrinogen (two separate experiments, each in duplicate, not shown). These experiments suggest that expression of the IL-1␤ promoter by fibrinogen-treated U937 cells may be mediated primarily via the CD11b/ CD18 fibrinogen receptor.
As indicated in MATERIALS AND METHODS, neither ADP nor ionomycin (both of which promote activation of the CD18 receptor into a high-affinity state [14] ) was used in these studies. Treatment of the cell cultures with these agents could have increased the sensitivity of the cells to fibrinogen. It is possible that the stress of cell isolation and transfection was sufficient to activate CD18 enough to produce the results reported.
The anti-CD18 mAb MAB1962, or clone P4H9, has been compared with a prototypical anti-CD18 clone, mAb 60.3 (30) . Both have a propensity to neutralize a number of leukocyte functions, such as monocyte adherence to endothelium, cell-mediated responses, and mitogen-induced cell proliferation (30) (31) (32) . In our experiments, MAB1962 . U937 cells were cotransfected with the 3.1-kb-LUC IL-1␤ promoter construct and competitive consensus oligonucleotides for CRE. Competition with CRE oligonucleotides permitted induction of the 3.1-kb IL-1␤ promoter construct by fibrinogen (Fbg). LUC activity is displayed relative to untreated control cells that were not cotransfected (relative stimulation Ϯ 1 SEM greater or less than a value of 1). ANOVA comparing the effect of CRE cotransfection on fibrinogen stimulation with fibrinogen or CRE treatment alone gave a value of P Ͻ 0.0001. Multiplecomparison testing showed that cotransfection with CRE oligonucleotide followed by fibrinogen treatment produced greater stimulation than did fibrinogen treatment alone (P Ͻ 0.05). CRE oligonucleotide alone did not affect constitutive expression of the 3.1-kb IL-1␤ promoter construct.
effectively inhibited fibrinogen induction of the IL-1␤ gene. The antibody alone did not induce the promoter, in keeping with the findings of Yurochko and associates, who found that mAb 60.3 did not induce IL-1␤ mRNA in normal human monocytes (33) . Thus, MAB1962 does not appear to behave as a surrogate ligand, but instead prevents the interaction of natural ligands, including fibrinogen, with a CD18 receptor.
Fibrinogen-Response Elements in the IL-1␤ Promoter Involving AP-1-, CRE-, and NF-B-like Motifs Regulate Transcription of IL-1␤
Transcription of IL-1␤ induced by fibrin appears to involve the complex interaction of several regulatory elements in the IL-1␤ promoter. Our study shows that NF-B, CREB, and AP-1 nuclear binding proteins are activated to interact with the IL-1␤ promoter after fibrinogen stimulation. The specificity of this interaction was supported by competitive cotransfection and gel-shift experiments using unlabeled consensus oligonucleotides. Once activated, NF-B, CREB, and AP-1 may induce or repress transcription of IL-1␤.
An important role for the transcription factor NF-B in inflammation has been described by in vitro studies (reviewed in Ref. 34) , by work in models of lung injury, and in patients with the acute respiratory distress syndrome (35) (36) (37) . Our findings are consistent with this role for NF-B and advance a mechanistic explanation for the postulated proinflammatory effects of fibrin(ogen) deposited in the injured lung. Specifically, we found that NF-B transcription factor was activated by fibrinogen and then interacted with an NF-B-like response element to induce the IL-1␤ promoter. Competition for the NF-B transcription factor by consensus oligonucleotide in fibrinogen-stimulated cells completely abrogated induction of the IL-1␤ promoter. Thus, an NF-B-like sequence appears to be a necessary fibrinogen response element in the transcriptional regulation of IL-1␤. It should be noted, however, that although our findings in the promoter-deletion experiments were corroborated by the cotransfection experiments, a causal link between binding and activation cannot be conclusively assumed.
cAMP pathways, which involve transactivation of CRE by CREB, can lead to induction or suppression of IL-1␤, depending on the experimental conditions (38, 39) . Increased levels of cAMP induced by LPS were found by Brandwein to suppress IL-1␤ synthesis in mouse peritoneal macrophages (38) . In contrast, Chandra and coworkers found that LPS-stimulated increases in cAMP enhanced IL-1␤ in THP-1 cells (39) . Therefore, differences in stimulating agents and cell types likely have a major role in transcriptional regulation of IL-1␤ (15) and should be taken into consideration when comparing one experimental system with another. Though we did not measure cAMP, interaction of CREBs with CREs suggested involvement of a fibrinogen-activated cAMP pathway that could have repressed IL-1␤ gene expression in our model. However, repression by CRE seemed to be conditional on upstream regulatory sequences, because even though CREB was activated in the cell nucleus after treatment with fibrinogen, induction of the full-length IL-1␤ promoter was not repressed. Only when upstream sequences containing AP-1 were deleted did CREB-CRE interaction repress the promoter. When this interaction was interrupted by competition for CREB with excess CRE oligonucleotides, the truncated promoter (3.1-kb LUC) was inducible by fibrinogen.
AP-1 response elements composed of combinations of the proto-oncogenes c-jun and c-fos are known to be involved in the transcriptional upregulation of IL-1␤ induced by phorbol esters (40) . We found that deletion of AP-1-containing sequences creating the 2.98-kb CAT or 3.1-kb LUC constructs resulted in complete loss of IL-1␤ promoter stimulation by fibrinogen. In the context of the cotransfection experiments showing that NF-B oligonucleotides blocked fibrinogen induction of the full-length promoter ( Figure 5 ) whereas CRE oligonucleotides recovered induction in the 3.1-kb construct (Figure 6 ), we suggest that activation of the upstream AP-1 or AP-1-like elements is required to permit IL-1␤ transcription in the intact promoter. We should also point out that known AP-1/CRE and AP-1 sequences downstream from the CRE element at position Ϫ2865 could potentially affect the induction or suppression of the IL-1␤ promoter in ways not detected by our experimental design. Thus, various combinations of activated AP-1/activating transcription factor (ATF)/CREB family heterodimeric nuclear binding proteins could regulate the degree to which fibrinogen induces transcription of IL-1␤.
Fibrin(ogen) as a Proinflammatory Molecule in Lung Injury
Plasma fibrinogen leaks into the extravascular spaces (41, 42) or is produced by alveolar epithelial cells (43) where it can be converted to fibrin under procoagulant conditions in injured and inflamed tissues (5, 44, 45) . There, fibrin(ogen) may interact with leukocytes bearing ␤ 2 integrin receptors to promote the synthesis of IL-1␤ and possibly other immediate/early inflammatory mediators such as tissue factor (46) . Coagulation factor X, the complement component C3bi, and intracellular adhesion molecules (ICAM)-1 and -2 also bind ␤ 2 integrins (47). It is possible, then, that activation of the coagulation or complement systems, or contact with damaged endothelium expressing increased ICAM, may also promote IL-1␤ induction via the ␤ 2 integrin family of leukocyte receptors. The signal transduction pathways activated by fibrin(ogen) and the other ␤ 2 integrin ligands are not completely understood, but may involve changes in cAMP, calcium fluxes, and even cell cytoskeletal rearrangements (13, 48) .
In conclusion, we have extended our previous work by elucidating some of the potential transcriptional regulatory mechanisms through which fibrin(ogen) induces IL-1␤. These mechanisms involve regions on the IL-1␤ promoter that enhance, permit, and, in some cases, may suppress transcription of IL-1␤. Although our study focused on fibrinogen stimulation of promoter sequences known to regulate IL-1␤ transcription, other as-yet-undescribed fibrin(ogen) response elements could also be involved in the regulation of this multifunctional inflammatory cytokine.
